JNCI Journal of the National Cancer Institute

1

Targeted Therapies for Renal Cell Carcinoma: Review of Adverse Event Management Strategies

Eisen, T., Sternberg, C. N., Robert, C., Mulders, P., Pyle, L., Zbinden, S., Izzedine, H., Escudier, B.

Journal:

Year:

2012

Language:

english

File:

PDF, 683 KB

english, 2012

2

Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up

Andriole, G. L., Crawford, E. D., Grubb, R. L., Buys, S. S., Chia, D., Church, T. R., Fouad, M. N., Isaacs, C., Kvale, P. A., Reding, D. J., Weissfeld, J. L., Yokochi, L. A., O'Brien, B., Ragard, L. R

Journal:

JNCI Journal of the National Cancer Institute

Year:

2012

Language:

english

File:

PDF, 379 KB

english, 2012

3

StatBite Drugs In Development By Therapeutic Area (2010)

Journal:

JNCI Journal of the National Cancer Institute

Year:

2012

File:

PDF, 106 KB

2012

4

Predicting the Value of Indexing Symptoms for Ovarian Cancer

Journal:

JNCI Journal of the National Cancer Institute

Year:

2012

Language:

english

File:

PDF, 90 KB

english, 2012

5

Cover

Journal:

JNCI Journal of the National Cancer Institute

Year:

2012

Language:

english

File:

PDF, 898 KB

english, 2012

6

Predictability of Adjuvant Trastuzumab Benefit in N9831 Patients Using the ASCO/CAP HER2-Positivity Criteria

Perez, E. A., Dueck, A. C., McCullough, A. E., Reinholz, M. M., Tenner, K. S., Davidson, N. E., Gralow, J., Harris, L. N., Kutteh, L. A., Hillman, D. W., Jenkins, R. B., Chen, B.

Journal:

JNCI Journal of the National Cancer Institute

Year:

2012

Language:

english

File:

PDF, 245 KB

english, 2012

7

Next Steps in Clinical Trial Redesign

Nicholas, J.

Journal:

JNCI Journal of the National Cancer Institute

Year:

2012

Language:

english

File:

PDF, 82 KB

english, 2012

9

Drug Approvals 2011: Focus on Companion Diagnostics

Goozner, M.

Journal:

JNCI Journal of the National Cancer Institute

Year:

2012

Language:

english

File:

PDF, 126 KB

english, 2012

10

Predictive Value of Symptoms for Ovarian Cancer: Comparison of Symptoms Reported by Questionnaire, Interview, and General Practitioner Notes

Lim, A. W. W., Mesher, D., Gentry-Maharaj, A., Balogun, N., Jacobs, I., Menon, U., Sasieni, P.

Journal:

JNCI Journal of the National Cancer Institute

Year:

2012

Language:

english

File:

PDF, 349 KB

english, 2012

11

Finding Ovarian Cancer

Hartge, P., Speyer, J. L.

Journal:

JNCI Journal of the National Cancer Institute

Year:

2012

Language:

english

File:

PDF, 119 KB

english, 2012

12

Adoptive Immunotherapy Poised To Deliver on Decades-Old Promise

Hede, K.

Journal:

JNCI Journal of the National Cancer Institute

Year:

2012

Language:

english

File:

PDF, 95 KB

english, 2012

13

IN THIS ISSUE

Journal:

JNCI Journal of the National Cancer Institute

Year:

2012

Language:

english

File:

PDF, 74 KB

english, 2012

14

Re: Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and -18 Infections

Mikolajczyk, R. T., Horn, J., Damm, O., Kaufmann, A. M., Kretzschmar, M. E. E.

Journal:

JNCI Journal of the National Cancer Institute

Year:

2012

Language:

english

File:

PDF, 58 KB

english, 2012

15

EDITORIAL BOARD

Journal:

JNCI Journal of the National Cancer Institute

Year:

2012

Language:

english

File:

PDF, 48 KB

english, 2012

16

ALK Gene Amplified in Most Inflammatory Breast Cancers

Tuma, R. S.

Journal:

JNCI Journal of the National Cancer Institute

Year:

2012

Language:

english

File:

PDF, 86 KB

english, 2012

17

InterSCOPE Study: Associations Between Esophageal Squamous Cell Carcinoma and Human Papillomavirus Serological Markers

Sitas, F., Egger, S., Urban, M. I., Taylor, P. R., Abnet, C. C., Boffetta, P., O'Connell, D. L., Whiteman, D. C., Brennan, P., Malekzadeh, R., Pawlita, M., Dawsey, S. M., Waterboer, T.

Journal:

JNCI Journal of the National Cancer Institute

Year:

2012

Language:

english

File:

PDF, 379 KB

english, 2012

18

YB-1, the E2F Pathway, and Regulation of Tumor Cell Growth

Lasham, A., Samuel, W., Cao, H., Patel, R., Mehta, R., Stern, J. L., Reid, G., Woolley, A. G., Miller, L. D., Black, M. A., Shelling, A. N., Print, C. G., Braithwaite, A. W.

Journal:

JNCI Journal of the National Cancer Institute

Year:

2012

Language:

english

File:

PDF, 885 KB

english, 2012

19

JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Journal:

JNCI Journal of the National Cancer Institute

Year:

2012

Language:

english

File:

PDF, 46 KB

english, 2012

20

Response: Re: Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and -18 Infections

Safaeian, M., Wacholder, S., Hildesheim, A.

Journal:

JNCI Journal of the National Cancer Institute

Year:

2012

Language:

english

File:

PDF, 70 KB

english, 2012

21

Study Shows no Evidence of a Mortality Benefit to PSA Screening

Journal:

JNCI Journal of the National Cancer Institute

Year:

2012

Language:

english

File:

PDF, 68 KB

english, 2012

Volume 104; Issue 2

JNCI Journal of the National Cancer Institute

Targeted Therapies for Renal Cell Carcinoma: Review of Adverse Event Management Strategies

Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up

StatBite Drugs In Development By Therapeutic Area (2010)

Predicting the Value of Indexing Symptoms for Ovarian Cancer

Cover

Predictability of Adjuvant Trastuzumab Benefit in N9831 Patients Using the ASCO/CAP HER2-Positivity Criteria

TABLE OF CONTENTS

Next Steps in Clinical Trial Redesign

Drug Approvals 2011: Focus on Companion Diagnostics

Predictive Value of Symptoms for Ovarian Cancer: Comparison of Symptoms Reported by Questionnaire, Interview, and General Practitioner Notes

Finding Ovarian Cancer

Adoptive Immunotherapy Poised To Deliver on Decades-Old Promise

IN THIS ISSUE

Re: Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and -18 Infections

EDITORIAL BOARD

ALK Gene Amplified in Most Inflammatory Breast Cancers

InterSCOPE Study: Associations Between Esophageal Squamous Cell Carcinoma and Human Papillomavirus Serological Markers

YB-1, the E2F Pathway, and Regulation of Tumor Cell Growth

JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Response: Re: Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and -18 Infections

Study Shows no Evidence of a Mortality Benefit to PSA Screening